Israel Fernández-Cadenas Selected Research

Israel Fernández-Cadenas Research Topics

Disease

24	Stroke (Strokes) 10/2022 - 12/2003
15	Ischemic Stroke 01/2022 - 07/2005
3	CADASIL 07/2021 - 09/2017
2	Hemorrhagic Stroke 08/2012 - 06/2006
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2009 - 07/2005
2	Brain Ischemia (Cerebral Ischemia) 11/2009 - 06/2006
2	Glycogen Storage Disease Type V (McArdle's Disease) 12/2006 - 09/2003
2	Brain Injuries (Brain Injury) 06/2006 - 07/2005
1	Hematoma 07/2021
1	Inflammation (Inflammations) 07/2021
1	COVID-19 03/2021
1	Hypersensitivity (Allergy) 01/2020
1	Atherosclerosis 01/2018
1	Cerebral Hemorrhage 03/2016
1	Thrombophilia 01/2016
1	Hemorrhage 02/2015
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 05/2013
1	Muscular Diseases (Myopathy) 05/2013
1	Muscular Dystrophies (Muscular Dystrophy) 05/2013
1	Embolic Stroke 08/2010
1	Gliosis 07/2009
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2008
1	Transient Ischemic Attack 05/2008
1	Infarction (Infarctions) 06/2006

Drug/Important Bio-Agent (IBA)

13	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021 - 12/2003
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2010
6	Proteins (Proteins, Gene)FDA Link 07/2021 - 07/2005
5	Biological ProductsIBA 06/2022 - 08/2017
4	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 07/2005
3	Pharmaceutical PreparationsIBA 06/2022 - 07/2021
3	Fibrinogen (Factor I)FDA Link 01/2016 - 05/2006
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2008 - 12/2003
2	Amyloid (Amyloid Fibrils)IBA 07/2021 - 07/2009
2	Epidermal Growth Factor (EGF)IBA 07/2021 - 01/2021
2	NucleotidesIBA 01/2021 - 05/2013
2	fibrin fragment D (D-dimer)IBA 08/2012 - 08/2010
2	5-Lipoxygenase-Activating ProteinsIBA 03/2012 - 01/2010
1	Unithiol (DMPS)IBA 10/2022
1	ProteomeIBA 03/2022
1	Dabigatran FDA Link 01/2022
1	tau Proteins (tau Protein)IBA 07/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2021
1	Genetic Markers (Genetic Marker)IBA 03/2021
1	ThrombomodulinIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	antithrombin III-protease complexIBA 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	VitaminsIBA 01/2021
1	Deoxyribonuclease I (Nickase)IBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 09/2017
1	GuanineIBA 08/2017
1	CytosineIBA 08/2017
1	Phosphates (Orthophosphate)IBA 08/2017
1	Terminator Codon (Termination Codon)IBA 05/2013
1	Karyopherins (Importin)IBA 05/2013
1	SecretagoginsIBA 08/2012
1	cerebellinIBA 08/2012
1	Caspase 3 (Caspase-3)IBA 08/2012
1	RNA (Ribonucleic Acid)IBA 05/2012
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2010
1	CytokinesIBA 11/2009
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2009
1	AnticoagulantsIBA 01/2009
1	Serine Proteases (Serine Protease)IBA 01/2009
1	Protein CIBA 01/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2008
1	E-SelectinIBA 05/2008
1	Lipoprotein(a)IBA 05/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2008
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2008
1	C-Reactive ProteinIBA 05/2008
1	Factor XIII (Coagulation Factor XIII)IBA 09/2006
1	FibrinIBA 09/2006
1	GelatinIBA 06/2006
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2006
1	Plasminogen Activator Inhibitor 1IBA 05/2006
1	Metalloproteases (Metalloproteinases)IBA 07/2005
1	Muscle Form Glycogen Phosphorylase (Myophosphorylase)IBA 09/2003
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 09/2003

Therapy/Procedure

6	Thrombolytic Therapy 01/2021 - 07/2005
5	Therapeutics 07/2021 - 07/2008
2	Secondary Prevention 01/2020 - 08/2010
1	Activities of Daily Living (ADL) 12/2006